Case Report
An Atypical Case of Shiga Toxin Producing-Escherichia Coli Hemolytic and Uremic Syndrome (STEC-HUS) in a Lung Transplant Recipient
| | Exams | Results |
| | Immunology | | | Complement | | | C3, mg/L (N: 880-1650) | 780 | | C4, mg/L (N: 100-380) | 107 | | CH50, % (N: 86-126) | 164 | | Factor H, % (N: 70-130) | 61 | | Antifactor H antibodies, UI (N: 0-300) | < 5 | | Factor I, % (N: 70-130) | 97 | | ADAMTS13 | | | Activity, % (N: 40-130) | 22 | | Anti-ADAMTS-13 antibodies, UI (N < 15) | < 1.0 | | Antineutrophil Cytoplasmic Antibodies (N < 20) | < 20 | | Antinuclear Antibodies (N < 160) | < 160 | | Antiphospholipid Antibody Syndrome | | | Anticardiolipin antibodies | negative | | Anti-β2GP1 antibodies | negative |
| | Infectiology | | | PCR Shiga toxin (rectum biopsy) | positive | | PCR Cytomegalovirus (blood and CSF) | negative | | PCR Epstein-Barr Virus (blood, in log cop/mL) | 2.8 | | HIV, HBV, HCV, HEV, Yersinia, Leptospira, Syphilis, Coxiella, Lyme serologies | negative |
|
|
TMA, thrombotic microangiopathy; CSF: cerebrospinal fluid; PCR: polymerase chain reaction.
|
